Equities

Shandong Pharmaceutical Glass Co Ltd

600529:SHH

Shandong Pharmaceutical Glass Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)25.60
  • Today's Change0.22 / 0.87%
  • Shares traded5.81m
  • 1 Year change-3.69%
  • Beta1.2533
Data delayed at least 15 minutes, as of Jun 14 2024 08:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

SHANDONG PHARMACEUTICAL GLASS CO., LTD is a China-based company principally engaged in the research and development, manufacture and distribution of pharmaceutical glass products. The Company's products include molded pharmaceutical glass bottles, ampoules, phials, brown bottles, butyl rubber plugs, aluminum tops and others. The Company distributes its products in domestic and overseas markets.

  • Revenue in CNY (TTM)5.01bn
  • Net income in CNY830.07m
  • Incorporated1993
  • Employees6.47k
  • Location
    Shandong Pharmaceutical Glass Co LtdYiyuan CountyZIBO 256100ChinaCHN
  • Phone+86 5 333259028
  • Fax+86 5 333249700
  • Websitehttp://www.pharmglass.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
FP Corp10.24bn540.50m9.13bn4.88k16.331.307.390.8916143.41143.412,718.421,795.700.74385.285.75--3.934.375.516.2830.2132.135.285.770.888860.180.388833.585.124.161.693.44-7.527.07
Scientex Bhd6.56bn774.12m10.33bn3.99k13.341.8610.501.570.32460.32462.752.320.7826--4.201,069,642.009.388.9813.7313.87--22.0011.9811.530.863747.620.161725.452.309.396.909.0212.658.45
Orora Ltd20.00bn695.53m12.61bn4.66k13.681.298.980.63050.14290.14294.021.520.98664.236.47894,545.903.434.404.896.6818.9519.003.483.420.80595.750.5299178.444.900.203-1.23-2.210.08462.29
Nine Dragons Paper (Holdings) Ltd56.18bn-702.43m14.82bn23.08k--0.33114.730.2638-0.1612-0.161212.8910.270.46275.5216.122,620,234.00-0.55153.53-0.73184.656.3213.07-1.195.620.72950.4690.610133.04-12.081.46-172.77--22.61--
Shandong Pharmaceutical Glass Co Ltd5.01bn830.07m16.99bn6.47k20.472.19--3.391.251.257.5511.690.54143.275.12774,457.608.969.1311.0611.7728.8229.7916.5615.462.67--0.081732.5618.9814.0325.4816.7114.0913.30
Toyo Seikan Group Holdings Ltd43.83bn1.06bn20.33bn19.98k19.390.65426.650.4638129.30129.305,360.043,832.350.81064.293.58--2.051.852.792.4812.4912.742.532.381.46--0.213862.684.933.69122.742.640.549945.09
Data as of Jun 14 2024. Currency figures normalised to Shandong Pharmaceutical Glass Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

13.09%Per cent of shares held by top holders
HolderShares% Held
T. Rowe Price International Ltd.as of 31 Mar 202418.34m2.76%
Hwabao WP Fund Management Co., Ltd.as of 30 Sep 202317.01m2.56%
Bank of Communications Schroder Fund Management Co., Ltd.as of 24 May 20239.56m1.44%
Caitong Fund Management Co., Ltd.as of 24 May 20237.43m1.12%
CITIC Securities Co., Ltd. (Invt Port)as of 31 Dec 20236.28m0.95%
GF Fund Management Co., Ltd.as of 30 Sep 20236.23m0.94%
Harvest Fund Management Co., Ltd.as of 30 Sep 20235.64m0.85%
Abu Dhabi Investment Authority (Investment Management)as of 30 Sep 20235.50m0.83%
China Life Asset Management Co., Ltd.as of 30 Sep 20235.49m0.83%
China Southern Asset Management Co., Ltd.as of 31 Dec 20235.40m0.81%
More ▼
Data from 30 Jun 2023 - 03 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.